Hot Pursuit     24-Dec-21
Ajanta Pharma gains on buyback proposal
Ajanta Pharma advanced 3.18% to Rs 2,123.90 after the company said that its board will meet on Tuesday, 28 December 2021, to consider a proposal for buy-back of equity shares of the company.

The announcement was made after trading hours yesterday, 23 December 20221.

Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.

The company's consolidated net profit rose 15.11% to Rs 195.94 crore on a 23.59% increase in sales to Rs 884.80 crore in Q2 FY22 over Q2 FY21.

Previous News
  Ajanta Pharma consolidated net profit rises 15.11% in the September 2021 quarter
 ( Results - Announcements 29-Oct-21   18:15 )
  Ajanta Pharma fixes record date for interim dividend
 ( Market Beat - Reports 29-Oct-21   15:36 )
  Ajanta Pharma fixes record date for interim dividend
 ( Market Beat - Reports 24-Jul-23   11:29 )
  Ajanta Pharma consolidated net profit rises 39.00% in the June 2016 quarter
 ( Results - Announcements 26-Jul-16   16:32 )
  Volumes soar at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 20-Dec-21   11:00 )
  Volumes spurt at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 20-Oct-23   11:00 )
  Ajanta Pharma
 ( Results - Analysis 29-Jul-22   11:30 )
  Ajanta Pharma provides update on USFDA inspection
 ( Corporate News - 09-Feb-17   11:01 )
  Ajanta Pharma standalone net profit rises 21.99% in the December 2015 quarter
 ( Results - Announcements 01-Feb-16   17:44 )
  Ajanta Pharma to pay interim dividend
 ( Corporate News - 27-Oct-16   16:36 )
  Neuland Laboratories Ltd Spurts 8.97%, S&P BSE Healthcare index Rises 1.07%
 ( Hot Pursuit - 03-Feb-21   09:30 )
Other Stories
  Dredging Corp hits the roof on bagging Rs 156-cr order from Cochin Port Authority
  04-Jul-24   16:55
  Zydus Life jumps on USFDA nod for BP lowering drug
  04-Jul-24   16:28
  Bank of Maharashtra Q1 gross advances climb 19% YoY
  04-Jul-24   15:41
  ITD Cementation India Ltd leads losers in 'A' group
  04-Jul-24   15:00
  Equitas SFB Q1 gross advances grow 18% YoY
  04-Jul-24   14:53
  Tata Motors UK JLR registration rises 5% YoY in June
  04-Jul-24   14:50
  Remedium Lifecare Ltd leads losers in 'B' group
  04-Jul-24   14:45
  Volumes soar at Astrazeneca Pharma India Ltd counter
  04-Jul-24   14:30
  Sun Pharma gains on EMA nod for Nidlegy
  04-Jul-24   14:18
  GRM Overseas rises after securing basmati rice supply order from Bin Awadh Alnaqeeb Group
  04-Jul-24   14:01
Back Top